We also demonstrate that WNT-16 and DVL3 expression is higher at baseline in fibroblasts of individuals with COPD stage II, although curiously this did not result in increased baseline expression of either total or active β-catenin. The gene discussed is DVL3; the disease is chronic obstructive pulmonary disease.